Immunotherapy: Cancer's New Frontier

Dr. Daruka Mahadevan and Eric Weterings examine cancer cells in a petri dish.
Anna C. Christensen, UA Cancer Center

Cancer patients' immune systems are receiving a boost from checkpoint inhibitors and other laboratory-made antibodies, which train T cells to attack cancer. An expanded understanding of cancer, genetics and immunobiology could revolutionize treatment. A team of UArizona researchers and clinicians, including several BIO5 members, are working at the leading edge of this fast-moving field.